# reload+after+2024-01-22 07:43:26.557397
address1§3027 Townsgate Road
address2§Suite 300
city§Westlake Village
state§CA
zip§91361
country§United States
phone§805 418 5006
website§https://www.arcutis.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
fullTimeEmployees§268
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Todd Franklin Watanabe M.A.', 'age': 55, 'title': 'President, CEO & Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1014052, 'exercisedValue': 271886, 'unexercisedValue': 4501377}, {'maxAge': 1, 'name': 'Dr. Bhaskar  Chaudhuri Ph.D.', 'age': 68, 'title': 'Co-Founder & Independent Director', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 59667, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Masaru  Matsuda Esq., J.D.', 'age': 52, 'title': 'Senior VP, General Counsel & Corporate Secretary', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 626218, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Patrick E. Burnett M.D., Ph.D.', 'age': 51, 'title': 'Senior VP & Chief Medical Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 689954, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John W. Smither CPA', 'age': 70, 'title': 'Interim CFO & Principal Accounting Officer', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 410752, 'exercisedValue': 1336807, 'unexercisedValue': 2289516}, {'maxAge': 1, 'name': 'Mr. Rajvir  Madan', 'title': 'Chief Digital & Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric  McIntyre', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Courtney  Barton', 'age': 40, 'title': 'VP and Chief Compliance Officer & Privacy Officer', 'yearBorn': 1983, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Amanda  Sheldon', 'title': 'Head of Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ayisha  Jeter', 'title': 'Head of Marketing & Market Access', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§6
compensationRisk§7
shareHolderRightsRisk§3
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.934
priceToSalesTrailing12Months§7.1400986
currency§USD
dateShortInterest§1702598400
forwardEps§-2.56
pegRatio§-0.11
exchange§NMS
quoteType§EQUITY
shortName§Arcutis Biotherapeutics, Inc.
longName§Arcutis Biotherapeutics, Inc.
firstTradeDateEpochUtc§1580481000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2fecbc50-3c9a-3138-8f51-5317e20e84cd
gmtOffSetMilliseconds§-18000000
targetHighPrice§20.0
targetLowPrice§6.0
targetMeanPrice§12.0
targetMedianPrice§9.5
recommendationMean§2.1
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§5.885
grossMargins§0.93421996
ebitdaMargins§0.0
trailingPegRatio§None
